logo

Synlogic Inc (SYBX)



Trade SYBX now with
  Date
  Headline
4/18/2018 7:04:29 AM Synlogic Doses First Subject In Phase 1/2a Trial Of SYNB1618 For Treatment Of Phenylketonuria
4/18/2018 7:04:27 AM Synlogic Doses First Subject In Phase 1/2a Trial Of SYNB1618 For Phenylketonuria
4/6/2018 8:35:46 AM Synlogic Agrees To Sell 3.28 Mln Shares To A Large Mutual Fund Investor In A Registered Direct Offering
4/2/2018 7:03:30 AM Synlogic Doses First Patient In Phase 1b/2a Trial Of SYNB1020 For Treatment Of Hyperammonemia In Patients With Cirrhosis
3/21/2018 10:00:36 AM Wedbush Is Cutting Synlogic Inc (SYBX) FY18 Estimate To -3.23 From -2.68
3/21/2018 10:00:21 AM Wedbush Is Cutting Synlogic Inc (SYBX) Q4 18 Estimate To -0.87 From -0.73
3/21/2018 10:00:06 AM Wedbush Is Cutting Synlogic Inc (SYBX) Q3 18 Estimate To -0.83 From -0.69
3/21/2018 9:59:43 AM Wedbush Is Lowering Synlogic Inc (SYBX) Q2 18 Estimate To -0.79 From -0.65
3/21/2018 9:59:17 AM Wedbush Is Lowering Synlogic Inc (SYBX) Q1 18 Estimate To -0.74 From -0.62
3/13/2018 6:35:35 AM Wedbush Is Raising Synlogic Inc (SYBX) FY18 Estimate To -2.68 From -3.35
3/13/2018 6:35:10 AM Wedbush Is Cutting Synlogic Inc (SYBX) Q4 18 Estimate To -0.73 From -0.72
3/13/2018 6:34:51 AM Wedbush Is Increasing Synlogic Inc (SYBX) Q3 18 Estimate To -0.69 From -0.94
3/13/2018 6:34:31 AM Wedbush Is Raising Synlogic Inc (SYBX) Q2 18 Estimate To -0.65 From -0.89
3/13/2018 6:34:15 AM Wedbush Is Raising Synlogic Inc (SYBX) Q1 18 Estimate To -0.62 From -0.84
1/24/2018 8:15:51 AM Synlogic Prices Public Offering Of 5.13 Mln Common Shares At $9.75 Per Share
1/23/2018 4:03:45 PM Synlogic Announces Proposed Public Offering Of Common Stock
1/5/2018 8:05:14 AM Synlogic Provides Overview Of Recent Progress And Outlined Key Objectives And Anticipated Milestones For 2018
12/8/2017 6:05:14 AM Synlogic, Ginkgo Bioworks Announce Collaboration To Discover New Living Medicines To Treat Neurological, Liver Disorders
11/27/2017 4:49:52 PM Wedbush Starts Synlogic Inc (SYBX) At Outperform With $20 Price Target